Pharmaceutical Companies

Gedeon Richter PLC. , Dorog

Country: 🇭🇺Hungary

Ownership: -

Established: -

Employees: -

Market Cap: $5.6B

Website: -

Gedeon Richter PLC. , Dorog

🇭🇺Hungary

Ownership: -

Established: -

Employees: -

Market Cap: $5.6B

Website: -

Siegfried Holding AG

Country: 🇨🇭Switzerland

Ownership: Public

Established: 1873-01-01

Employees: 3.8K

Market Cap: $5.6B

Website: http://www.siegfried.ch

Siegfried Holding AG

🇨🇭Switzerland

Ownership: Public

Established: 1873-01-01

Employees: 3.8K

Market Cap: $5.6B

Website: http://www.siegfried.ch

Madrigal Pharmaceuticals

Country: 🇺🇸United States

Ownership: Public

Established: 2016-01-01

Employees: 276

Market Cap: $5.5B

Website: http://www.madrigalpharma.com

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West...

Madrigal Pharmaceuticals

🇺🇸United States

Ownership: Public

Established: 2016-01-01

Employees: 276

Market Cap: $5.5B

Website: http://www.madrigalpharma.com

ROHTO PHARMACEUTICAL CO., LTD.

Country: 🇯🇵Japan

Ownership: Public

Established: 1899-02-22

Employees: 7.2K

Market Cap: $5.4B

Website: http://www.rohto.co.jp

ROHTO PHARMACEUTICAL CO., LTD.

🇯🇵Japan

Ownership: Public

Established: 1899-02-22

Employees: 7.2K

Market Cap: $5.4B

Website: http://www.rohto.co.jp

Nuvalent

Country: 🇺🇸United States

Ownership: Public

Established: 2017-01-01

Employees: 92

Market Cap: $5.4B

Website: http://www.nuvalent.com

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Nuvalent

🇺🇸United States

Ownership: Public

Established: 2017-01-01

Employees: 92

Market Cap: $5.4B

Website: http://www.nuvalent.com

SCHOTT Pharma AG & Co. KGaA

Country: 🇩🇪Germany

Ownership: -

Established: -

Employees: -

Market Cap: $5.4B

Website: -

SCHOTT Pharma AG & Co. KGaA

🇩🇪Germany

Ownership: -

Established: -

Employees: -

Market Cap: $5.4B

Website: -

Ultragenyx México, S. de R.L. de C.V.

Country: 🇲🇽Mexico

Ownership: -

Established: -

Employees: -

Market Cap: $5.3B

Website: -

Ultragenyx México, S. de R.L. de C.V.

🇲🇽Mexico

Ownership: -

Established: -

Employees: -

Market Cap: $5.3B

Website: -

Avidity Biosciences

Country: 🇺🇸United States

Ownership: Public

Established: 2013-01-01

Employees: 253

Market Cap: $5.1B

Website: http://www.aviditybiosciences.com

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more...